$PALI

2 theses

bullish 100%neutral 0%bearish 0%

Avg return (1w)

+1.3%

Win rate (1w)

50% (2 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 28, 4:15 PM ET

$PALIr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish

u/Avish_Golakiya · 118d ago31 prior · 63% at 3mo

“long several of these”

5 of the 6 biotech names I posted 5 weeks ago hit their catalyst (and the 1 that hasn't)

FDA cleared IND for PALI-2108 and global Phase 2 in ulcerative colitis, enabling next-stage development. Early-stage catalyst with strong risk/reward asymmetry, though capital needs remain.

At post $2.10Now $1.19-43.3% since postedas of Oct 28, 4:15 PM ET

1d—

3d—

1w-6.2%

1m-9.5%

3m-35.7%

6m—

1y—

original post →

$PALIr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish

u/Avish_Golakiya · 135d ago31 prior · 63% at 3mo

Upcoming penny stock catalysts for June/July 2026 in Biotech and Pharma

Positive Phase 1b data in fibrostenotic Crohn's (March) with unusually thick sell-side coverage (Piper Sandler, Wolfe, Stifel, HC Wainwright at Buy) and $18.50 consensus price target versus $2 current price. Early stage with capital raise needed but represents real shot on goal.

At post $1.69Now $1.19-29.6% since postedas of Oct 28, 4:15 PM ET

1d+5.3%

3d+10.7%

1w+8.9%

1m+20.1%

3m+21.9%

6m—

1y—

original post →

End of results.